Citations (99)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Li-Shiun Chen, Sarah M Hartz, Timothy B Baker, Yinjiao Ma, Nancy L Saccone & Laura J Bierut. (2018) Use of Polygenic Risk Scores of Nicotine Metabolism in Predicting Smoking Behaviors. Pharmacogenomics 19:18, pages 1383-1394.
Read now
Read now
Dimitrios Xirofotos, Eftihios Trakakis, Moli Peppa, Charalambos Chrelias, Pericles Panagopoulos, Chrysi Christodoulaki, Dimos Sioutis & Dimitrios Kassanos. (2016) The amount and duration of smoking is associated with aggravation of hormone and biochemical profile in women with PCOS. Gynecological Endocrinology 32:2, pages 143-146.
Read now
Read now
Aryeh I Herman, Elise E DeVito, Kevin P Jensen & Mehmet Sofuoglu. (2014) Pharmacogenetics of Nicotine Addiction: Role of Dopamine. Pharmacogenomics 15:2, pages 221-234.
Read now
Read now
Alexandra Elizabeth Shields, Mehdi Najafzadeh & Anna Boonin Schachter. (2013) Bumps Along the Translational Pathway: Anticipating Uptake of Tailored Smoking Cessation Treatment. Personalized Medicine 10:8, pages 813-825.
Read now
Read now
Diane Snow & Julie Hue Lu. (2012) Genetics and Genomics: Unraveling New Opportunities for Addiction Treatment and Education. Journal of Addictions Nursing 23:2, pages 93-96.
Read now
Read now
Robert A Schnoll & Frank T Leone. (2011) Biomarkers to Optimize the Treatment of Nicotine Dependence. Biomarkers in Medicine 5:6, pages 745-761.
Read now
Read now
Articles from other publishers (93)
Zheng-Ming Ding, Elizabeth M Neslund, Dongxiao Sun & Xiaoying Tan. (2024) Methoxsalen Inhibits the Acquisition of Nicotine Self-Administration: Attenuation by Cotinine Replacement in Male Rats. Nicotine and Tobacco Research.
Crossref
Crossref
Mingda Liu, Hongjuan Wang, Yaning Fu, Xiangyu Li, Ping Wu, Guanglin Liu, Ruiyan Wang, Yuan Zhang, Huan Chen, Hongwei Hou & Qingyuan Hu. (2024) The Role of Nicotine Metabolic Rate on Nicotine Dependence and Rewarding: Nicotine Metabolism in Chinese Male Smokers and Male Mice. Molecular Neurobiology.
Crossref
Crossref
Brian Patrick Murray & Emily Anne Kiernan. (2024) Physiologic Effects of Substance Use. Emergency Medicine Clinics of North America 42:1, pages 69-91.
Crossref
Crossref
Pengfei Han, Xiaoyuan Jing, Shulei Han, Xinsheng Wang, Qiannan Li, Yuan Zhang, Pengpeng Yu, Xin-an Liu, Ping Wu, Huan Chen, Hongwei Hou & Qingyuan Hu. (2023) Pharmacokinetic differences in nicotine and nicotine salts mediate reinforcement-related behavior: an animal model study. Frontiers in Neuroscience 17.
Crossref
Crossref
Gissela Borrego‐Soto, Yadira Xitlalli Perez‐Paramo, Francisco Hernández‐Cabrera, Fatima Miroslaba Alvarado‐Monroy, Gilberto Borrego, Alejandro Robles‐Zamora, Philip Lazarus & Augusto Rojas‐Martinez. (2023) Biochemical and genetic biomarkers associated with nicotine dependence in Mexican smokers. Pharmacology Research & Perspectives 11:5.
Crossref
Crossref
Maria Montes de Oca & Maria Eugenia Laucho-Contreras. (2023) Smoking cessation and vaccination. European Respiratory Review 32:167, pages 220187.
Crossref
Crossref
Scott Veldhuizen, Anjali Behal, Laurie Zawertailo & Peter Selby. (2023) Adequacy of nicotine replacement and success quitting tobacco in clinical populations: An observational study. Drug and Alcohol Dependence 244, pages 109796.
Crossref
Crossref
Anu Kallio, Auli Suominen, Mimmi Tolvanen, Kari Rantavuori, Heidi Jussila, Linnea Karlsson, Hasse Karlsson & Satu Lahti. (2023) Concurrent changes in dental anxiety and smoking in parents of the FinnBrain Birth Cohort Study. European Journal of Oral Sciences 131:1.
Crossref
Crossref
Eduardo R. Butelman, Brian Reed, Vadim Yuferov & Mary Jeanne Kreek. 2023. Neurobiology of Brain Disorders. Neurobiology of Brain Disorders
793
809
.
Helmut Brath, Susanne Kaser, Christian Tatschl, Stephanie Fischer-See & Peter Fasching. (2023) Rauchen, erhitzte Tabakprodukte, Alkohol und Diabetes mellitus (Update 2023)Smoking, heated tobacco products, alcohol and diabetes mellitus (update 2023). Wiener klinische Wochenschrift 135:S1, pages 84-90.
Crossref
Crossref
Huijie Li, Qiang Wang, Suyun Li & Chongqi Jia. (2022) Effects of Genetic Variants in the Nicotine Metabolism Pathway on Smoking Cessation. Genetics Research 2022, pages 1-9.
Crossref
Crossref
Lisa R. Goldberg & Thomas J. Gould. (2022) Genetic influences impacting nicotine use and abuse during adolescence: Insights from human and rodent studies. Brain Research Bulletin 187, pages 24-38.
Crossref
Crossref
Robert Uliński, Iwona Kwiecień & Joanna Domagała-Kulawik. (2022) Lung Cancer in the Course of COPD-Emerging Problems Today. Cancers 14:15, pages 3819.
Crossref
Crossref
Bernard Le Foll, Megan E. Piper, Christie D. Fowler, Serena Tonstad, Laura Bierut, Lin Lu, Prabhat Jha & Wayne D. Hall. (2022) Tobacco and nicotine use. Nature Reviews Disease Primers 8:1.
Crossref
Crossref
Jaclyn Parks, Kathleen E. McLean, Lawrence McCandless, Russell J. de Souza, Jeffrey R. Brook, James Scott, Stuart E. Turvey, Piush J. Mandhane, Allan B. Becker, Meghan B. Azad, Theo J. Moraes, Diana L. Lefebvre, Malcolm R. Sears, Padmaja Subbarao & Tim K. Takaro. (2021) Assessing secondhand and thirdhand tobacco smoke exposure in Canadian infants using questionnaires, biomarkers, and machine learning. Journal of Exposure Science & Environmental Epidemiology 32:1, pages 112-123.
Crossref
Crossref
Jaroslav A. Hubacek, Ivana Kurcova, Vera Maresova, Alexandra Pankova, Lenka Stepankova, Kamila Zvolska, Vera Lanska & Eva Kralikova. (2021) SNPs within CHRNA5-A3-B4 and CYP2A6/B6, nicotine metabolite concentrations and nicotine dependence treatment success in smokers. Biomedical Papers 165:1, pages 84-89.
Crossref
Crossref
Julia Sasiadek, Nicole Durham & Tony P. George. 2021. Textbook of Addiction Treatment. Textbook of Addiction Treatment
197
214
.
Dwight O. DeayIIIIII, Kim K. Colvert, Fei Gao, Steve Seibold, Priyanka Goyal, Daniel Aillon, Peter A. Petillo & Mark L. Richter. (2020) An active site mutation in 6-hydroxy-l-Nicotine oxidase from Arthrobacter nicotinovorans changes the substrate specificity in favor of (S)-nicotine. Archives of Biochemistry and Biophysics 692, pages 108520.
Crossref
Crossref
Natalie NiepothAndres Bendesky. (2020) How Natural Genetic Variation Shapes Behavior. Annual Review of Genomics and Human Genetics 21:1, pages 437-463.
Crossref
Crossref
Chantal Farra, Nada Assaf, Nathalie Karaky, Sara Diab, Ghazi Zaatari, Najwa Cortas & Rose T. Daher. (2020) Association between CYP2A6 genotypes and smoking behavior in Lebanese smokers. Meta Gene 23, pages 100616.
Crossref
Crossref
Yen-Chu Chen, James P. Fowler, Jing Wang, Christy J. W. Watson, Yasmine Sherafat, Andres Staben, Philip Lazarus, Travis T. Denton & Christie D. Fowler. (2020) The Novel CYP2A6 Inhibitor, DLCI-1, Decreases Nicotine Self-Administration in Mice. Journal of Pharmacology and Experimental Therapeutics 372:1, pages 21-29.
Crossref
Crossref
Hana M. Hammad, Amer Imraish, Belal Azab, Al M. Best, Yousef S. Khader & Malek Zihlif. (2019) Associations of CYP2A6 Gene Polymorphism with Smoking Status Among Jordanians: Gender-Related Differences. Current Drug Metabolism 20:9, pages 765-770.
Crossref
Crossref
George R. Uhl, George F. Koob & Jennifer Cable. (2019) The neurobiology of addiction. Annals of the New York Academy of Sciences 1451:1, pages 5-28.
Crossref
Crossref
Keran Jiang, Zhongli Yang, Wenyan Cui, Kunkai Su, Jennie Z Ma, Thomas J Payne & Ming D Li. (2019) An Exome-Wide Association Study Identifies New Susceptibility Loci for Age of Smoking Initiation in African- and European-American Populations. Nicotine & Tobacco Research 21:6, pages 707-713.
Crossref
Crossref
Rachel J Keith, Daniel W Riggs, Daniel J Conklin, Pawel Lorkiewicz, Sanjay Srivastava, Aruni Bhatnagar & Andrew P DeFilippis. (2019) Nicotine Metabolism in Adults With Type 2 Diabetes. Nicotine & Tobacco Research 21:6, pages 846-849.
Crossref
Crossref
Lion Shahab, Linda Bauld, Ann McNeill & Rachel F. Tyndale. (2018) Does the nicotine metabolite ratio moderate smoking cessation treatment outcomes in real‐world settings? A prospective study. Addiction 114:2, pages 304-314.
Crossref
Crossref
Tanya Agurs-CollinsSusan PerskyElectra D. PaskettShari L. BarkinHelen I. MeissnerTonja R. NanselSonia S. ArteagaXinzhi ZhangRina DasTilda Farhat. (2019) Designing and Assessing Multilevel Interventions to Improve Minority Health and Reduce Health Disparities. American Journal of Public Health 109:S1, pages S86-S93.
Crossref
Crossref
Mark I. Ryder, Elizabeth T. Couch & Benjamin W. Chaffee. (2018) Personalized periodontal treatment for the tobacco‐ and alcohol‐using patient. Periodontology 2000 78:1, pages 30-46.
Crossref
Crossref
Lanqing Wang, John T. Bernert, Neal L. Benowitz, June Feng, Peyton JacobIIIIII, Ernest McGahee, Samuel P. Caudill, Gerhard Scherer, Max Scherer, Nikola Pluym, Mira V. Doig, Kirk Newland, Sharon E. Murphy, Nicolas J. Caron, Lane C. Sander, Makiko Shimizu, Hiroshi Yamazaki, Sung Kim, Loralie J. Langman, Jeanita S. Pritchett, Lorna T. Sniegoski, Yao Li, Benjamin C. Blount & James L. Pirkle. (2018) Collaborative Method Performance Study of the Measurement of Nicotine, Its Metabolites, and Total Nicotine Equivalents in Human Urine. Cancer Epidemiology, Biomarkers & Prevention 27:9, pages 1083-1090.
Crossref
Crossref
Taraneh Taghavi, Maria Novalen, Caryn Lerman, Tony P. George & Rachel F. Tyndale. (2018) A Comparison of Direct and Indirect Analytical Approaches to Measuring Total Nicotine Equivalents in Urine. Cancer Epidemiology, Biomarkers & Prevention 27:8, pages 882-891.
Crossref
Crossref
Lindsay Henderson, Katrina Claw, Erica Woodahl, Renee Robinson, Bert Boyer, Wylie Burke & Kenneth Thummel. (2018) P450 Pharmacogenetics in Indigenous North American Populations. Journal of Personalized Medicine 8:1, pages 9.
Crossref
Crossref
Emily Olfson, Joseph Bloom, Sarah Bertelsen, John P Budde, Naomi Breslau, Andrew Brooks, Robert Culverhouse, Grace Chan, Li‐Shiun Chen, David Chorlian, Danielle M Dick, Howard J Edenberg, Sarah Hartz, Dorothy Hatsukami, Victor M Hesselbrock, Eric O Johnson, John R Kramer, Samuel Kuperman, Jacquelyn L Meyers, John Nurnberger, Bernice Porjesz, Nancy L Saccone, Marc A Schuckit, Jerry Stitzel, Jay A Tischfield, John P Rice, Alison Goate & Laura J Bierut. (2016)
CYP2A6
metabolism in the development of smoking behaviors in young adults
. Addiction Biology 23:1, pages 437-447.
Crossref
Crossref
Aleksi Tornio & Janne T. Backman. 2018. Pharmacogenetics. Pharmacogenetics
3
32
.
Ming D. LiMing D. Li. 2018. Tobacco Smoking Addiction: Epidemiology, Genetics, Mechanisms, and Treatment. Tobacco Smoking Addiction: Epidemiology, Genetics, Mechanisms, and Treatment
153
181
.
Lion Shahab, Emily Mortimer, Linda Bauld, Jennifer A. McGowan, Ann McNeill & Rachel F. Tyndale. (2017) Characterising the nicotine metabolite ratio and its association with treatment choice: A cross sectional analysis of Stop Smoking Services in England. Scientific Reports 7:1.
Crossref
Crossref
Tracy T SmithLaura E RupprechtRachel L Denlinger-ApteJillian J WeeksRachel S PanasEric C DonnyAlan F Sved. (2017) Animal Research on Nicotine Reduction: Current Evidence and Research Gaps. Nicotine & Tobacco Research 19:9, pages 1005-1015.
Crossref
Crossref
R Gupta, B Qaiser, L He, T S Hiekkalinna, A B Zheutlin, S Therman, M Ollikainen, S Ripatti, M Perola, V Salomaa, L Milani, T D Cannon, P A F Madden, T Korhonen, J Kaprio & A Loukola. (2017) Neuregulin signaling pathway in smoking behavior. Translational Psychiatry 7:8, pages e1212-e1212.
Crossref
Crossref
Cheyenne Allenby & Mary Falcone. (2017) Using Genetics to Improve Addiction Treatment Outcomes. Current Behavioral Neuroscience Reports 4:1, pages 1-9.
Crossref
Crossref
Meghan Hewlett, Erika Chow, Ann Aschengrau & Shruthi Mahalingaiah. (2017) Prenatal Exposure to Endocrine Disruptors: A Developmental Etiology for Polycystic Ovary Syndrome. Reproductive Sciences 24:1, pages 19-27.
Crossref
Crossref
Stefano Fogli, Alessandro Saba, Marzia Del Re, Francesco Pistelli, Ferruccio Aquilini, Riccardo Zucchi, Antonio Palla, Maria Cristina Breschi, Laura Carrozzi & Romano Danesi. (2016) Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting. Journal of Pharmaceutical and Biomedical Analysis 131, pages 208-213.
Crossref
Crossref
Leah S. Richmond-Rakerd, Jacqueline M. Otto, Wendy S. Slutske, Cindy L. Ehlers, Kirk C. Wilhelmsen & Ian R. Gizer. (2016) A Novel Tobacco Use Phenotype Suggests the 15q25 and 19q13 Loci May be Differentially Associated With Cigarettes per Day and Tobacco-Related Problems. Nicotine & Tobacco Research, pages ntw260.
Crossref
Crossref
Victoria L. Stevens, Eric J. Jacobs, Susan M. Gapstur, Brian D. Carter, Mia M. Gaudet, J. Lee Westmaas & Alpa V. Patel. (2016) Evaluation of a Novel Difficulty of Smoking Cessation Phenotype Based on Number of Quit Attempts. Nicotine & Tobacco Research, pages ntw234.
Crossref
Crossref
Zhongli Yang, Tanseli Nesil, Kaitlyn P. Connaghan, Ming D. Li & Sulie L. Chang. (2016) Modulation Effect of HIV-1 Viral Proteins and Nicotine on Expression of the Immune-Related Genes in Brain of the HIV-1 Transgenic Rats. Journal of Neuroimmune Pharmacology 11:3, pages 562-571.
Crossref
Crossref
J Yang & M D Li. (2016) Converging findings from linkage and association analyses on susceptibility genes for smoking and other addictions. Molecular Psychiatry 21:8, pages 992-1008.
Crossref
Crossref
Noah R. Gubner, Aleksandra Kozar-Konieczna, Izabela Szoltysek-Boldys, Ewa Slodczyk-Mankowska, Jerzy Goniewicz, Andrzej Sobczak, Peyton JacobIIIIII, Neal L. Benowitz & Maciej L. Goniewicz. (2016) Cessation of alcohol consumption decreases rate of nicotine metabolism in male alcohol-dependent smokers. Drug and Alcohol Dependence 163, pages 157-164.
Crossref
Crossref
Dale S. Cannon, Robin J. Mermelstein, Tait R. Medina, Oksana Pugach, Donald Hedeker & Robert B. Weiss. (2016)
CYP2A6
Effects on Subjective Reactions to Initial Smoking Attempt
. Nicotine & Tobacco Research 18:5, pages 637-641.
Crossref
Crossref
J. Chan, T. Oshiro, S. Thomas, A. Higa, S. Black, A. Todorovic, F. Elbarbry & J. P. Harrelson. (2016) Inactivation of CYP2A6 by the Dietary Phenylpropanoid trans-Cinnamic Aldehyde (Cinnamaldehyde) and Estimation of Interactions with Nicotine and Letrozole. Drug Metabolism and Disposition 44:4, pages 534-543.
Crossref
Crossref
Dale S. Cannon, Tait R. Medina, Robin J. Mermelstein, Donald Hedeker, Amanda V. Bakian, Hilary Coon, Edwin H. Cook, Cindy Hamil & Robert B. Weiss. (2016)
CYP2A6
Longitudinal Effects in Young Smokers
. Nicotine & Tobacco Research 18:2, pages 196-203.
Crossref
Crossref
Naomi Sato, Tomonori Sato & Haruhiko Sugimura. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
1046
1054
.
Janet K. Coller, Daniel T. Barratt & Andrew A. Somogyi. 2016. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents
565
577
.
Jacob G. Dubroff, Robert K. Doot, Mary Falcone, Robert A. Schnoll, Riju Ray, Rachel F. Tyndale, Arthur L. Brody, Catherine Hou, Alexander Schmitz & Caryn Lerman. (2015) Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism. Journal of Nuclear Medicine 56:11, pages 1724-1729.
Crossref
Crossref
Anu Loukola, Jadwiga Buchwald, Richa Gupta, Teemu Palviainen, Jenni H?llfors, Emmi Tikkanen, Tellervo Korhonen, Miina Ollikainen, Antti-Pekka Sarin, Samuli Ripatti, Terho Lehtim?ki, Olli Raitakari, Veikko Salomaa, Richard J. Rose, Rachel F. Tyndale & Jaakko Kaprio. (2015) A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism. PLOS Genetics 11:9, pages e1005498.
Crossref
Crossref
Frank C. Bandiera, Kathryn C. Ross, Seyedehtaraneh Taghavi, Kevin Delucchi, Rachel F. Tyndale & Neal L. Benowitz. (2015) Nicotine Dependence, Nicotine Metabolism, and the Extent of Compensation in Response to Reduced Nicotine Content Cigarettes. Nicotine & Tobacco Research 17:9, pages 1167-1172.
Crossref
Crossref
Li-Shiun Chen, Timothy B. Baker, Douglas Jorenby, Megan Piper, Nancy Saccone, Eric Johnson, Naomi Breslau, Dorothy Hatsukami, Robert M. Carney & Laura J. Bierut. (2015) Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation. Drug and Alcohol Dependence 154, pages 278-282.
Crossref
Crossref
Sangkeun Chung, Sun S. Kim, Nisha Kini, Hua J. Fang, David Kalman & Douglas M. Ziedonis. (2013) Smoking Topography in Korean American and White Men: Preliminary Findings. Journal of Immigrant and Minority Health 17:3, pages 860-866.
Crossref
Crossref
Osama Y. Alshogran, Judith Naud, Andrew J. Ocque, François A. Leblond, Vincent Pichette & Thomas D. Nolin. (2015) Effect of Experimental Kidney Disease on the Functional Expression of Hepatic Reductases. Drug Metabolism and Disposition 43:1, pages 100-106.
Crossref
Crossref
Yuma Tega, Shin-ichi Akanuma, Yoshiyuki Kubo & Ken-ichi Hosoya. (2015)
Involvement of the H
+
/Organic Cation Antiporter in Nicotine Transport in Rat Liver
. Drug Metabolism and Disposition 43:1, pages 89-92.
Crossref
Crossref
Kristen M. Mackowick & Tony P. George. 2015. Textbook of Addiction Treatment: International Perspectives. Textbook of Addiction Treatment: International Perspectives
415
436
.
Steven J. Simmons & Thomas J. Gould. (2014)
Involvement of neuronal β
2
subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: Implications for pharmacotherapies
. Journal of Clinical Pharmacy and Therapeutics 39:5, pages 457-467.
Crossref
Crossref
Deniz Bagdas, Pretal P. Muldoon, Andy Z.X. Zhu, Rachel F. Tyndale & M. Imad Damaj. (2014) Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice. Neuropharmacology 85, pages 67-72.
Crossref
Crossref
Catherine H. Demers, Ryan Bogdan & Arpana Agrawal. (2014) The Genetics, Neurogenetics and Pharmacogenetics of Addiction. Current Behavioral Neuroscience Reports 1:1, pages 33-44.
Crossref
Crossref
Li‐Shiun Chen, A. Joseph Bloom, Timothy B. Baker, Stevens S. Smith, Megan E. Piper, Maribel Martinez, Nancy Saccone, Dorothy Hatsukami, Alison Goate & Laura Bierut. (2013)
Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (
CYP2A6
)
. Addiction 109:1, pages 128-137.
Crossref
Crossref
Christie D. Fowler & Paul J. Kenny. (2014) Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability. Neuropharmacology 76, pages 533-544.
Crossref
Crossref
Laura R. Stroud, George D. Papandonatos, Edmond Shenassa, Daniel Rodriguez, Raymond Niaura, Kaja Z. LeWinn, Lewis P. Lipsitt & Stephen L. Buka. (2014) Prenatal Glucocorticoids and Maternal Smoking During Pregnancy Independently Program Adult Nicotine Dependence in Daughters: A 40-Year Prospective Study. Biological Psychiatry 75:1, pages 47-55.
Crossref
Crossref
L. Li, K. Jia, X. Zhou, S. E. McCallum, L. B. Hough & X. Ding. (2013) Impact of Nicotine Metabolism on Nicotine's Pharmacological Effects and Behavioral Responses: Insights from a Cyp2a(4/5)bgs-Null Mouse. Journal of Pharmacology and Experimental Therapeutics 347:3, pages 746-754.
Crossref
Crossref
Sean P. David, David R. Strong, Adam M. Leventhal, Molly A. Lancaster, John E. McGeary, Marcus R. Munafò, Andrew W. Bergen, Gary E. Swan, Neal L. Benowitz, Rachel F. Tyndale, David V. Conti, Richard A. Brown, Caryn Lerman & Raymond Niaura. (2013) Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. Addiction 108:12, pages 2202-2211.
Crossref
Crossref
K J Bough, C Lerman, J E Rose, F J McClernon, P J Kenny, R F Tyndale, S P David, E A Stein, G R Uhl, D V Conti, C Green & S Amur. (2013) Biomarkers for Smoking Cessation. Clinical Pharmacology & Therapeutics 93:6, pages 526-538.
Crossref
Crossref
Riccardo Polosa & Pasquale CaponnettoSylviane de Viron. 2013. Advances in Smoking Cessation. Advances in Smoking Cessation
98
114
.
Lingjun Zuo, Xiang‐Yang Zhang, Fei Wang, Chiang‐Shan R. Li, Lingeng Lu, Liefu Ye, Heping Zhang, John H. Krystal, Hong‐Wen Deng & Xingguang Luo. (2012)
Genome‐Wide Significant Association Signals in
IPO
11‐
HTR
1
A
Region Specific for Alcohol and Nicotine Codependence
. Alcoholism: Clinical and Experimental Research 37:5, pages 730-739.
Crossref
Crossref
Nancy A Rigotti. (2013) Smoking cessation in patients with respiratory disease: existing treatments and future directions. The Lancet Respiratory Medicine 1:3, pages 241-250.
Crossref
Crossref
Meghan J. Chenoweth, Jennifer O’Loughlin, Marie-Pierre Sylvestre & Rachel F. Tyndale. (2013) CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers. Pharmacogenetics and Genomics 23:4, pages 232-235.
Crossref
Crossref
Stephen S. Hecht. (2012) Lung carcinogenesis by tobacco smoke. International Journal of Cancer 131:12, pages 2724-2732.
Crossref
Crossref
Henry R. Kranzler & James R. McKay. (2012) Personalized Treatment of Alcohol Dependence. Current Psychiatry Reports 14:5, pages 486-493.
Crossref
Crossref
W H Berrettini & G A Doyle. (2011) The CHRNA5–A3–B4 gene cluster in nicotine addiction. Molecular Psychiatry 17:9, pages 856-866.
Crossref
Crossref
Gideon St.Helen, Maria Novalen, Daniel F. Heitjan, Delia Dempsey, Peyton JacobIIIIII, Adel Aziziyeh, Victoria C. Wing, Tony P. George, Rachel F. Tyndale & Neal L. Benowitz. (2012) Reproducibility of the Nicotine Metabolite Ratio in Cigarette Smokers. Cancer Epidemiology, Biomarkers & Prevention 21:7, pages 1105-1114.
Crossref
Crossref
Scott I. Vrieze, Matt McGue & William G. Iacono. (2012) The interplay of genes and adolescent development in substance use disorders: leveraging findings from GWAS meta-analyses to test developmental hypotheses about nicotine consumption. Human Genetics 131:6, pages 791-801.
Crossref
Crossref
Allison B. Gold & Caryn Lerman. (2012) Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. Human Genetics 131:6, pages 857-876.
Crossref
Crossref
Lingjun Zuo, Fengyu Zhang, Heping Zhang, Xiang‐Yang Zhang, Fei Wang, Chiang‐Shan R. Li, Lingeng Lu, Jiang Hong, Lin Lu, John Krystal, Hong‐Wen Deng & Xingguang Luo. (2012) Genome‐wide search for replicable risk gene regions in alcohol and nicotine co‐dependence. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 159B:4, pages 437-444.
Crossref
Crossref
David P King, Sara Paciga, Eve Pickering, Neal L Benowitz, Laura J Bierut, David V Conti, Jaakko Kaprio, Caryn Lerman & Peter W Park. (2011) Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials. Neuropsychopharmacology 37:3, pages 641-650.
Crossref
Crossref
Joshua E. Muscat, Kwangmi Ahn, John P. RichieJrJr & Steven D. Stellman. (2011) Nicotine dependence phenotype and lung cancer risk. Cancer 117:23, pages 5370-5376.
Crossref
Crossref
Li-Shiun Chen, Timothy B. Baker, Richard Grucza, Jen C. Wang, Eric O. Johnson, Naomi Breslau, Dorothy Hatsukami, Stevens S. Smith, Nancy Saccone, Scott Saccone, John P. Rice, Alison M. Goate & Laura J. Bierut. (2011) Dissection of the Phenotypic and Genotypic Associations With Nicotinic Dependence. Nicotine & Tobacco Research 14:4, pages 425-433.
Crossref
Crossref
Oliver West, Peter Hajek & Hayden McRobbie. (2011) Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence. Psychopharmacology 218:2, pages 313-322.
Crossref
Crossref
Matthew A. Steliga & Carolyn M. Dresler. (2011) Epidemiology of Lung Cancer: Smoking, Secondhand Smoke, and Genetics. Surgical Oncology Clinics of North America 20:4, pages 605-618.
Crossref
Crossref
Mary Falcone, Christopher Jepson, Neal Benowitz, Andrew W. Bergen, Angela Pinto, E. Paul Wileyto, Don Baldwin, Rachel F. Tyndale, Caryn Lerman & Riju Ray. (2011) Association of the Nicotine Metabolite Ratio and CHRNA5/CHRNA3 Polymorphisms With Smoking Rate Among Treatment-Seeking Smokers. Nicotine & Tobacco Research 13:6, pages 498-503.
Crossref
Crossref
Tobias Raupach & Constant P. (Onno) van Schayck. (2011) Pharmacotherapy for Smoking Cessation. CNS Drugs 25:5, pages 371-382.
Crossref
Crossref
Andrew A. Strasser, Neal L. Benowitz, Angela G. Pinto, Kathy Z. Tang, Stephen S. Hecht, Steve G. Carmella, Rachel F. Tyndale & Caryn E. Lerman. (2011) Nicotine Metabolite Ratio Predicts Smoking Topography and Carcinogen Biomarker Level. Cancer Epidemiology, Biomarkers & Prevention 20:2, pages 234-238.
Crossref
Crossref
Ikumi Washio, Makiko Maeda, Chika Sugiura, Ryota Shiga, Mitsuhiro Yoshida, Shinpei Nonen, Yasushi Fujio & Junichi Azuma. (2011) Cigarette Smoke Extract Induces CYP2B6 through Constitutive Androstane Receptor in Hepatocytes. Drug Metabolism and Disposition 39:1, pages 1-3.
Crossref
Crossref
Gang Chen, Nino E. GiambroneJr.Jr., Douglas F. Dluzen, Joshua E. Muscat, Arthur Berg, Carla J. Gallagher & Philip Lazarus. (2010) Glucuronidation Genotypes and Nicotine Metabolic Phenotypes: Importance of Functional UGT2B10 and UGT2B17 Polymorphisms. Cancer Research 70:19, pages 7543-7552.
Crossref
Crossref
Susanne Cupisti, Lothar Häberle, Ralf Dittrich, Patricia G. Oppelt, Christine Reissmann, Desiree Kronawitter, Matthias W. Beckmann & Andreas Mueller. (2010) Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistance. Fertility and Sterility 94:2, pages 673-677.
Crossref
Crossref
Thorgeir E Thorgeirsson, Daniel F Gudbjartsson, Ida Surakka, Jacqueline M Vink, Najaf Amin, Frank Geller, Patrick Sulem, Thorunn Rafnar, Tõnu Esko, Stefan Walter, Christian Gieger, Rajesh Rawal, Massimo Mangino, Inga Prokopenko, Reedik Mägi, Kaisu Keskitalo, Iris H Gudjonsdottir, Solveig Gretarsdottir, Hreinn Stefansson, John R Thompson, Yurii S Aulchenko, Mari Nelis, Katja K Aben, Martin den Heijer, Asger Dirksen, Haseem Ashraf, Nicole Soranzo, Ana M Valdes, Claire Steves, André G Uitterlinden, Albert Hofman, Anke Tönjes, Peter Kovacs, Jouke Jan Hottenga, Gonneke Willemsen, Nicole Vogelzangs, Angela Döring, Norbert Dahmen, Barbara Nitz, Michele L Pergadia, Berta Saez, Veronica De Diego, Victoria Lezcano, Maria D Garcia-Prats, Samuli Ripatti, Markus Perola, Johannes Kettunen, Anna-Liisa Hartikainen, Anneli Pouta, Jaana Laitinen, Matti Isohanni, Shen Huei-Yi, Maxine Allen, Maria Krestyaninova, Alistair S Hall, Gregory T Jones, Andre M van Rij, Thomas Mueller, Benjamin Dieplinger, Meinhard Haltmayer, Steinn Jonsson, Stefan E Matthiasson, Hogni Oskarsson, Thorarinn Tyrfingsson, Lambertus A Kiemeney, Jose I Mayordomo, Jes S Lindholt, Jesper Holst Pedersen, Wilbur A Franklin, Holly Wolf, Grant W Montgomery, Andrew C Heath, Nicholas G Martin, Pamela A F Madden, Ina Giegling, Dan Rujescu, Marjo-Riitta Järvelin, Veikko Salomaa, Michael Stumvoll, Tim D Spector, H-Erich Wichmann, Andres Metspalu, Nilesh J Samani, Brenda W Penninx, Ben A Oostra, Dorret I Boomsma, Henning Tiemeier, Cornelia M van Duijn, Jaakko Kaprio, Jeffrey R Gulcher, Mark I McCarthy, Leena Peltonen, Unnur Thorsteinsdottir & Kari Stefansson. (2010) Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior. Nature Genetics 42:5, pages 448-453.
Crossref
Crossref
. (2010) Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nature Genetics 42:5, pages 441-447.
Crossref
Crossref
C Lerman, C Jepson, E P Wileyto, F Patterson, R Schnoll, M Mroziewicz, N Benowitz & R F Tyndale. (2010) Genetic Variation in Nicotine Metabolism Predicts the Efficacy of Extended-Duration Transdermal Nicotine Therapy. Clinical Pharmacology & Therapeutics 87:5, pages 553-557.
Crossref
Crossref
Gustavo L. Kortmann, Cristina J. Dobler, Lisiane Bizarro & Claiton H.D. Bau. (2009) Pharmacogenetics of smoking cessation therapy. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153B:1, pages 17-28.
Crossref
Crossref